EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immortalization and Targeted Enrichment of HIV-Infected CD4+ T-Cells from Patients Under Antiretroviral Therapy

Whitney E Bruchey, Sharada Paudel, Ashley L McCormack iD, Tomozumi Imamichi iD, Sylvain Laverdure iD

International Journal of Molecular Sciences · 22.01.2026 · 27 (2) · 1086

DOI: 10.3390/ijms27021086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.01.2026. Verfasst von Whitney E Bruchey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, MD 21702, USA. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, HIV Infections, HIV-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Defective HIV-1 proviruses harboring mutations and/or large internal deletions represent the majority of HIV-1 sequences found in circulating peripheral blood mononuclear cells of people living with HIV with viremia suppressed by combination antiretroviral therapy; indirect evidence suggests that such sequences are transcriptionally active and may contribute to immune activation. In this study, we present a new approach allowing for high-efficiency screening, immortalization, and targeted enrichment of HIV-positive CD4+ T-cells isolated from people living with HIV. Using this method, we were able to isolate and expand patient-derived cells, identify mutations and deletions via sequencing, and confirm that those proviruses were transcriptionally and translationally active in vitro. Moreover, our findings indicate that the majority of proviral sequences circulating in suppressed HIV-infected patients may undergo 3′-LTR deletions, suggesting that sequence diversity reported using LTR-to-LTR amplification and sequencing approaches may indeed be underscored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD4-Positive T-LymphocytesHIV InfectionsHIV-1HumansProvirusesHIV Long Terminal RepeatMutation

Stichwörter der Autor:innen

CD4+ T-cellsHIV-1cloningdefective provirusesimmortalizationpatient-derived

Autor:innen und Institutionen

  • Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, MD 21702, USA.
  • Biopharmaceutical Developmental Program, Frederick National Laboratory, Frederick, MD 21702, USA.

ORCID-Profile: Ashley L McCormack, Tomozumi Imamichi, Sylvain Laverdure

Förderung

  • NCI NIH HHS
  • National Cancer Institute, National Institutes of Health
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health

Zitieren

APA

Bruchey, W. E., Paudel, S., McCormack, A. L., Imamichi, T., & Laverdure, S. (2026). Immortalization and Targeted Enrichment of HIV-Infected CD4+ T-Cells from Patients Under Antiretroviral Therapy. International Journal of Molecular Sciences, 27(2), 1086. https://doi.org/10.3390/ijms27021086

Vancouver

Bruchey WE, Paudel S, McCormack AL, Imamichi T, Laverdure S. Immortalization and Targeted Enrichment of HIV-Infected CD4+ T-Cells from Patients Under Antiretroviral Therapy. International Journal of Molecular Sciences. 2026;27(2):1086. doi:10.3390/ijms27021086

BibTeX
@article{Bruchey2026,
  author = {Bruchey, Whitney E and Paudel, Sharada and McCormack, Ashley L and Imamichi, Tomozumi and Laverdure, Sylvain},
  title = {Immortalization and Targeted Enrichment of HIV-Infected CD4+ T-Cells from Patients Under Antiretroviral Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {2},
  pages = {1086},
  doi = {10.3390/ijms27021086}
}
Kostenlos starten →